Clinical trial

Intraoperative Frozen Section Pathology to Diagnose the IASLC Grades for Lung Adenocarcinoma (ECTOP-1014)

NCT05794698

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

PROCEDURE · Unmapped registry intervention Surgical resection Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Intraoperative Frozen Section Pathology to Diagnose the IASLC Grades for Lung Adenocarcinoma (ECTOP-1014)

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2022-01-01

PhaseN/A

Conditions

Lung Adenocarcinomaverified · MONDO: lung adenocarcinoma

Surgical Procedure, Unspecifiedunresolved

Pathologyunresolved

Interventions

Surgical resectionPROCEDURE

Sponsors & collaborators

Fudan Universitylead sponsor

Shanghai Pulmonary Hospital, Shanghai, Chinacollaborator

Tongji Hospital, Wuhan, Hubei Province, Chinacollaborator

Sixth People's Hospital, Shanghai, Chinacollaborator

Ningbo Clinical Pathological Diagnostic Center, Ningbo, Zhejiang Province, Chinacollaborator

Dongfang Hospital Affiliated to Tongji University, Shanghai, Chinacollaborator

People's Hospital of Jiangdu, Yangzhou, Jiangsu Province, Chinacollaborator

Liaocheng People's Second Hospital, Liaocheng, Shandong Province, Chinacollaborator

Guanxian People's Hospital, Liaocheng, Shandong Province, Chinacollaborator

Zhoupu Hospital, Pudong New Area, Shanghai, Chinacollaborator

Mapped research locations

ShanghaiShanghai Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05794698 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.